The First Dipeptide Mimetic of Neurotrofin-3: Design and Pharmacological Properties.
Animal research · 2022
- What was studied
- Cell cultures and mice
- Main finding
- GTS-301 activated TrkC and TrkB, protected HT-22 cells in injury assays and showed antidepressant-like activity in a mouse forced-swim experiment.
Study data at a glance
- Participants or experimental model
- Cell cultures and mice
- Reported results
- GTS-301 activated TrkC and TrkB, protected HT-22 cells in injury assays and showed antidepressant-like activity in a mouse forced-swim experiment.
Study limitations and source details
Study limitations
- Preclinical findings do not establish human benefit or safety.
- Abstract only. Full methods and independent replication remain unconfirmed.
Source details
Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Abstract reviewed
Sources checked
Citation
Gudasheva TA, Sazonova NM, Tarasiuk AV, Logvinov IO, Antipova TA, Nikiforov DM, Povarnina PY, Seredenin SB. The First Dipeptide Mimetic of Neurotrofin-3: Design and Pharmacological Properties. Doklady. Biochemistry and biophysics
Study source ↗ · DOI 10.1134/s1607672922040032 · Bibliography entry · Link to this summary